Detalhe da pesquisa
1.
An international review of the characteristics of viral nucleic acid-amplification testing (NAT) reveals a trend towards the use of smaller pool sizes and individual donation NAT.
Vox Sang
; 2024 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38516962
2.
International review of blood donation nucleic acid amplification testing.
Vox Sang
; 119(4): 315-325, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38390819
3.
Hepatitis A virus (HAV) RNA detection in Polish blood donors and likely transmissions through blood components during the 2017-2019 epidemic.
Transfusion
; 63(2): 349-359, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36537152
4.
Introduction of EUBIS standards to upgrade inspections of blood establishments to improve the safety of blood transfusion: The Polish experience.
Transfus Med
; 33(6): 460-466, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37732379
5.
Deferral of donor vaccinated for HIV.
Transfusion
; 63(2): 435-436, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36733256
6.
Molecular and serological infection marker screening in blood donors indicates high endemicity of hepatitis E virus in Poland.
Transfusion
; 58(5): 1245-1253, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29492976
7.
Hemovigilance survey of pathogen-reduced blood components in the Warsaw Region in the 2009 to 2013 period.
Transfusion
; 56 Suppl 1: S39-44, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27001360
8.
International Forum on Transfusion Practices in Haematopoietic Stem-Cell Transplantation: Summary.
Vox Sang
; 116(5): 609-612, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33866564
9.
International Forum on Transfusion Practices in Haematopoietic Stem-Cell Transplantation: Responses.
Vox Sang
; 116(5): e25-e43, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33866580
10.
Introducing Pathogen Reduction Technology in Poland: A Cost-Utility Analysis.
Transfus Med Hemother
; 42(3): 158-65, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26195929
11.
Blood donors screening for blood born viruses in Poland.
Przegl Epidemiol
; 69(3): 473-7, 591-5, 2015.
Artigo
em Inglês, Polonês
| MEDLINE | ID: mdl-26519842
12.
Methods of freezing cord blood hematopoietic stem cells.
Transfusion
; 54(1): 194-202, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23621822
13.
International Forum on Occult hepatitis B infection and transfusion safety.
Vox Sang
; 114(4): e1-e35, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30972757
14.
International forum on Occult hepatitis B infection and transfusion safety.
Vox Sang
; 114(4): 397-406, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30818422
15.
Evaluation and experience from routine use of chemiluminescence assays for serological screening of blood and plasma donations on the Alinity s system and the Alinity i system, two new fully-automated immunoassay systems in Poland.
Pract Lab Med
; 39: e00364, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38328514
16.
Head-to-head comparison of two transcription-mediated amplification assay versions for detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus Type 1 in blood donors.
Transfusion
; 53(10 Pt 2): 2512-24, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23590145
17.
[Emerging infectious diseases in the context of blood safety]. / Nowo pojawiajace sie choroby zakazne w aspekcie bezpieczenstwa krwi.
Acta Haematol Pol
; 44(3): 284-293, 2013.
Artigo
em Polonês
| MEDLINE | ID: mdl-32226059
18.
[Parvovirus B19 DNA testing in Polish blood donors, 2004-2010]. / Badanie DNA parvowirusa B19 (B19V) u Polskich dawcoów krwi, 2004-2010.
Przegl Epidemiol
; 66(1): 7-12, 2012.
Artigo
em Polonês
| MEDLINE | ID: mdl-22708291
19.
[Analysis of the prevalence of HBV markers relevant to the risk of reactivation of infection in patients with hematologic diseases]. / Analiza wystepowania markerów wirusa HBV istotnych dla ryzyka reaktywacji zakazenia u osób z chorobami hematologicznymi.
Przegl Epidemiol
; 66(1): 1-5, 2012.
Artigo
em Polonês
| MEDLINE | ID: mdl-22708290
20.
Human Intramuscular Hyperimmune Gamma Globulin (hIHGG) Anti-SARS-CoV-2-Characteristics of Intermediates and Final Product.
Viruses
; 14(6)2022 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35746798